Hossein Nejadnik
Overview
Explore the profile of Hossein Nejadnik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
1315
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jung K, Theruvath A, Nejadnik H, Liu A, Xing L, Sulchek T, et al.
Sci Rep
. 2022 Feb;
12(1):2955.
PMID: 35194089
Regenerative medicine uses the patient own stem cells to regenerate damaged tissues. Molecular imaging techniques are commonly used to image the transplanted cells, either right after surgery or at a...
2.
Kiru L, Zlitni A, Tousley A, Dalton G, Wu W, Lafortune F, et al.
Proc Natl Acad Sci U S A
. 2022 Feb;
119(6).
PMID: 35101971
Metastatic osteosarcoma has a poor prognosis with a 2-y, event-free survival rate of ∼15 to 20%, highlighting the need for the advancement of efficacious therapeutics. Chimeric antigen receptor (CAR) T-cell...
3.
Atashgah R, Ghasemi A, Raoufi M, Abdollahifar M, Zanganeh S, Nejadnik H, et al.
Mol Pharm
. 2021 Jul;
18(8):3171-3180.
PMID: 34279974
Current treatment of chronic wounds has been critically limited by various factors, including bacterial infection, biofilm formation, impaired angiogenesis, and prolonged inflammation. Addressing these challenges, we developed a multifunctional wound...
4.
Theruvath A, Mahmoud E, Wu W, Nejadnik H, Kiru L, Liang T, et al.
Am J Sports Med
. 2021 Apr;
49(7):1861-1870.
PMID: 33872071
Background: The transplantation of mesenchymal stem cells (MSCs) into cartilage defects has led to variable cartilage repair outcomes. Previous in vitro studies have shown that ascorbic acid and reduced iron...
5.
Muehe A, Nejadnik H, Muehe H, Rosenberg J, Gharibi H, Saei A, et al.
Biointerphases
. 2021 Mar;
16(1):011008.
PMID: 33706522
Ferumoxytol nanoparticles are being used clinically for the treatment of anemia and molecular imaging in patients. It is well documented that while most patients tolerate ferumoxytol well, a small percentage...
6.
Theruvath A, Aghighi M, Iv M, Nejadnik H, Lavezo J, Pisani L, et al.
Nanotheranostics
. 2020 Jul;
4(4):195-200.
PMID: 32637297
Recent evidence of gadolinium deposition in the brain has raised safety concerns. Iron oxide nanoparticles are re-emerging as promising alternative MR contrast agents, because the iron core can be metabolized....
7.
Nejadnik H, Jung K, Theruvath A, Kiru L, Liu A, Wu W, et al.
Theranostics
. 2020 Jun;
10(13):6024-6034.
PMID: 32483435
Autologous therapeutic cells are typically harvested and transplanted in one single surgery. This makes it impossible to label them with imaging biomarkers through classical transfection techniques in a laboratory. To...
8.
Theruvath A, Nejadnik H, Lenkov O, Yerneni K, Li K, Kuntz L, et al.
Radiology
. 2019 May;
292(1):129-137.
PMID: 31063081
Background Cartilage repair outcomes of matrix-associated stem cell implants (MASIs) in patients have been highly variable. Conventional MRI cannot help distinguish between grafts that will and grafts that will not...
9.
Nejadnik H, Tseng J, Daldrup-Link H
Wiley Interdiscip Rev Nanomed Nanobiotechnol
. 2019 Feb;
11(4):e1552.
PMID: 30734542
"Off the shelf" allogeneic stem cell transplants and stem cell nano-composites are being used for the treatment of degenerative bone diseases. However, major and minor histocompatibility antigens of therapeutic cell...
10.
Mohanty S, Yerneni K, Theruvath J, Graef C, Nejadnik H, Lenkov O, et al.
Cell Death Dis
. 2019 Jan;
10(2):36.
PMID: 30674867
CD47 monoclonal antibodies (mAbs) activate tumor-associated macrophages (TAMs) in sarcomas to phagocytose and eliminate cancer cells. Though CD47 mAbs have entered clinical trials, diagnostic tests for monitoring therapy response in...